source
- Experimental exon-skipping drug from Avidity Biosciences shows early improvement in a Duchenne patientA recent story follows two teenage boys living with Duchenne muscular dystrophy, a rare and fatal muscle‑wasting condition. While one boy’s health continues to decline, the other, a 12‑year‑old nam…
- Caribou Biosciences shuts down after failing to fund late-stage CAR-T lymphoma trialCaribou Biosciences, a biotech co-founded by Nobel laureate Jennifer Doudna, announced it is shutting down. The closure follows the company's inability to raise the funding required for a Phase 3…